WallStSmart
SNOA

Sonoma Pharmaceuticals Inc

NASDAQ: SNOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.10
+3.77% today

Updated 2026-04-30

Market cap
$4.98M
P/E ratio
P/S ratio
0.28x
EPS (TTM)
$-1.95
Dividend yield
52W range
$1 – $7
Volume
0.2M

Sonoma Pharmaceuticals Inc (SNOA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-20.52M$-18.08M$-17.45M$-16.83M$-6.64M$-4.43M$-4.03M$1.15M$-4.89M$-6.69M$-8.75M$-8.17M$-12.44M$-11.72M$-4.59M$-3.38M$-4.25M$-6.15M$-2.40M$-88000.00
Capital expenditures$475000.00$873000.00$617000.00$393000.00$141000.00$174000.00$336000.00$257000.00$504000.00$139000.00$345000.00$394000.00$187000.00$100000.00$206000.00$179000.00$137000.00$269000.00$17000.00$80000.00
Depreciation
Stock-based comp$1.58M$2.26M$1.43M$2.37M$2.80M$1.60M$1.45M$1.77M$2.34M$2.15M$2.41M$1.64M$839000.00$371000.00$382000.00$669000.00$516000.00$224000.00
Free cash flow$-21.00M$-18.95M$-18.06M$-17.23M$-6.78M$-4.60M$-4.37M$893000.00$-5.39M$-6.83M$-9.09M$-8.56M$-12.63M$-11.82M$-4.80M$-3.56M$-4.38M$-6.42M$-2.42M$-168000.00
Investing cash flow
Financing cash flow
Dividends paid$0.00$2.56M$0.00$6.53M$6.14M$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-2.42M$656000.00$1.33M$9.99M$-7.39M$-6.38M$2000.00$529000.00